Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9314
+0.0314 (3.49%)
Jun 18, 2025, 4:00 PM - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $33.68 million as of June 18, 2025. Its market cap has decreased by -2.20% in one year.
Market Cap
33.68M
Enterprise Value
32.77M
1-Year Change
-2.20%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $33.68M, an increase of 1,794.95%. That is a compound annual growth rate of 201.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2025 | 32.55M | -25.03% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |